Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Micropapillary serous carcinoma of the ovary: an immunohistochemical and mutational analysis of p53.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists - 1 Jan 1998

Katabuchi H, Tashiro H, Cho K R, Kurman R J, Hedrick Ellenson L

Abstract excerpt

Micropapillary serous carcinoma (MPSC) has recently been described as a distinct ovarian neoplasm that shares histologic features with both serous borderline tumors (SBTs) and typical serous carcinomas of the ovary. To further define the relationship of MPSC to these two neoplasms, we evaluated all three tumor types for expression of the p53 protein and p53 gene mutations. The majority of MPSCs demonstrated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, p53
Share to Immunohistochemistry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Ovarian Neoplasms

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 9475193
DOI: 10.1097/00004347-199801000-00010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Micropapillary serous carcinoma of the ovary: an immunohistochemical and mutational analysis of p53.PMID 9475193Read ↗

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.Semantic proximity Read ↗

Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor).Semantic proximity Read ↗

Serous borderline tumours of the ovary.Semantic proximity Read ↗

Incidence of P53 and K-ras alterations in ovarian mucinous and serous tumors.Semantic proximity Read ↗

High-grade and low-grade pelvic serous neoplasms demonstrate differential p53 immunoreactivity in peritoneal washings.Semantic proximity Read ↗

Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing.Semantic proximity Read ↗

Is Invasive Micropapillary Serous Carcinoma a Low-grade Carcinoma?Semantic proximity Read ↗

The frequency and prognostic role of P53 and P16 immunoexpression in primary ovarian mucinous tumors.Semantic proximity Read ↗

Germ line and somatic mutations of BRAF V599E in ovarian carcinoma.Semantic proximity Read ↗

Evaluation of MTAP immunohistochemistry loss of expression in ovarian serous borderline tumors as a potential marker for prognosis and progression.Semantic proximity Read ↗

Low-grade serous neoplasms of the ovary with transformation to high-grade carcinomas: a report of 3 cases.Semantic proximity Read ↗

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.